Pre-vaccine-specific SARS-CoV-2 cellular responses were evaluated in 10 PID patients with median (IQR) IFN-γ levels of 80.5 (0–270) mUI/mL, which is significantly lower with respect to post-vaccination levels (p < 0.001) (Figure 2B). This evidence concerns the gene IFNG and pelvic inflammatory disease.